Lakefront Biotherapeutics | GLPG - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Biogen USD 18.65B 394.9M 2026-03
Genmab DKK 5.85B 96M 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Incyte USD 6.34B 721.58M 2026-06
Merck EUR 29.74B 1.15B 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03